title: Histological evaluation of scar tissue inflammatory response: the role of hGH in diabetic rats.
abstract: This paper describes a polymer site-specific delivery system containing human growth hormone in an in vivo model of scarring in the diabetic state. Copolymer discs with the hormone were introduced into incisions made in rats previously injected with streptozotocin in order to induce diabetes. Tissue specimens for evaluation were obtained at 3, 7 or 10 days after the procedure. Study groups were healthy rats and diabetic rats untreated or treated with/without the hormone. Histological sections were prepared for light microscopy examination of wound zones. Three and 7 days after surgery, polymer remains could be observed in the subcutaneous tissue. These remnants induced a moderate foreign body reaction. The number of macrophages detected was directly related to neovessel formation and metalloelastase expression. The CD4+/CD8+ ratio was low during the initial follow up stages (3 and 7 days) in untreated diabetic rats, yet an increased ratio corresponding to areas around the polymer remains was noted in the animals treated with copolymer loaded with the growth hormone. Copolymer is biodegradable in vivo and may be used as a vehicle for the slow release of active substances. The presence of the hormone at the site of skin injury induces cell proliferation and enhances the repair process.
authors.affiliation: Department of Medical Especialities, Faculty of Medicine, University of Alcalá, 28871 Alcalá de Henares, Madrid, Spain.
authors.forename: F
authors.initials: F
authors.lastname: García-Esteo
authors.forename: G
authors.initials: G
authors.lastname: Pascual
authors.forename: N
authors.initials: N
authors.lastname: García-Honduvilla
authors.forename: A
authors.initials: A
authors.lastname: Gallardo
authors.forename: J
authors.initials: J
authors.lastname: San Román
authors.forename: J M
authors.initials: JM
authors.lastname: Bellón
authors.forename: J
authors.initials: J
authors.lastname: Buján
mesh_terms: D000818:Animals; D002921:Cicatrix / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004195:Disease Models, Animal; D004794:Enzyme Repression / Q000235:genetics / Q000502:physiology; D006133:Growth Substances / Q000494:pharmacology*; D019382:Human Growth Hormone / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D008297:Male; D053508:Matrix Metalloproteinase 12; D008666:Metalloendopeptidases / Q000096:biosynthesis / Q000235:genetics; D018919:Neovascularization, Physiologic / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar
chemical_list: D006133:Growth Substances; D019382:Human Growth Hormone; D008666:Metalloendopeptidases; C507122:MMP12 protein, human; D053508:Matrix Metalloproteinase 12